← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1026 | 1026 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0215 | 71285-0215-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1026 | 1026 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1026 | 1026 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6056 | 72196-6056-1 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1026 | 1026 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-771 | 70004-771-44 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1026 | 1026 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2107 | 72627-2107-3 | Nandrolone Decanoate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate; Ketorolac Tromethamine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1026 | 1026 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-13 | Oxycodone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1026 | 1026 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1027 | 1027 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6616 | 71300-6616-4 | Ketamine HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1027 | 1027 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1027 | 1027 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0213 | 71285-0213-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1027 | 1027 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-563 | 72833-563-30 | Methionine; Choline Chloride; Inositol; Benzyl Alcohol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1027 | 1027 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1065 | 71266-1065-1 | Methylprednisolone Acetate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1027 | 1027 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1027 | 1027 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69324-051 | 69324-051-01 | Lysine Hydrochloride; Arginine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1027 | 1027 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8095 | 71285-8095-1 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1027 | 1027 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5020 | 71266-5020-2 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1027 | 1027 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1027 | 1027 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate; Ketorolac Tromethamine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1027 | 1027 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-25 | Oxycodone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1027 | 1027 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1027 | 1027 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1027 | 1027 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-045 | 70092-045-05 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1027 | 1027 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1028 | 1028 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-575 | 70092-575-36 | Diltiazem PF 125mg in 125ml D5W IVB | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1028 | 1028 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0214 | 71285-0214-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-567 | 72833-567-30 | Methionine; Choline Chloride; Inositol; Cyanocobalamin; Benzyl Alcohol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-8025 | 73271-8025-1 | Methylprednisolone Acetate; Lidocaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride Tetrahydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5105 | 26436-5105-5 | Magnesium Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8096 | 71285-8096-1 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5025 | 71266-5025-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-103 | 71449-103-11 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9017 | 83826-9017-8 | Moxifloxacin Hydrochloride; Ketorolac Tromethamine; Prednisolone Sodium Phosphate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1028 | 1028 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1028 | 1028 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1028 | 1028 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1028 | 1028 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0104 | 83863-0104-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1028 | 1028 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1029 | 1029 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-517 | 70092-517-43 | Morphine PF 1 mg/ml in 1 ml NS- 3 ml syr | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1029 | 1029 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1029 | 1029 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0112 | 72196-0112-1 | Magnesium Sulfate Heptahydrate; Tromethamine; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Magnesium Chloride; Sodium Acetate; Potassium Chloride; Mannitol | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1029 | 1029 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Choline Chloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1029 | 1029 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3121 | 62295-3121-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1029 | 1029 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride; Zinc Sulfate; Copper Gluconate; Sodium Selenite; Manganese Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1029 | 1029 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride Tetrahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1029 | 1029 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8097 | 71285-8097-1 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1029 | 1029 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5015 | 71266-5015-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1029 | 1029 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1029 | 1029 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9014 | 83826-9014-5 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1029 | 1029 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1029 | 1029 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1029 | 1029 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1029 | 1029 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1029 | 1029 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1030 | 1030 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6726 | 71300-6726-2 | Lidocaine | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1030 | 1030 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Succinylcholine Chloride; Cyanocobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1030 | 1030 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3122 | 62295-3122-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1030 | 1030 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1030 | 1030 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1030 | 1030 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-165 | 82396-165-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1030 | 1030 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1031 | 1031 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-063 | 73198-063-30 | Olympia Vita-Complex | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1031 | 1031 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Succinylcholine Chloride; Cyanocobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1031 | 1031 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6147 | 72196-6147-1 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1031 | 1031 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1031 | 1031 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8097 | 71285-8097-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1031 | 1031 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1031 | 1031 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-166 | 82396-166-01 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1031 | 1031 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1032 | 1032 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-615 | 81375-615-01 | Moxifloxacin SI | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1032 | 1032 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1032 | 1032 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1032 | 1032 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methohexital Sodium | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1032 | 1032 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1032 | 1032 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7080 | 71285-7080-1 | Magnesium Sulfate Heptahydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1032 | 1032 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6148 | 72196-6148-1 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1032 | 1032 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1032 | 1032 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7036 | 71285-7036-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1032 | 1032 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1032 | 1032 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9016 | 83826-9016-8 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1032 | 1032 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1032 | 1032 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1032 | 1032 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1032 | 1032 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1032 | 1032 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1033 | 1033 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5482 | 26436-5482-1 | ACS | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1033 | 1033 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1033 | 1033 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1033 | 1033 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1505 | 5446-1505-01 | Methotrexate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1033 | 1033 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1033 | 1033 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1033 | 1033 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6048 | 72196-6048-1 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1033 | 1033 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1033 | 1033 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0334 | 60652-0334-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1033 | 1033 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-03 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1033 | 1033 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1033 | 1033 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-004 | 72055-004-01 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1033 | 1033 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1033 | 1033 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1033 | 1033 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1033 | 1033 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1034 | 1034 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-140 | 73198-140-10 | PGE-2 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1034 | 1034 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-255 | 70004-255-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:1034 | 1034 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0111 | 72196-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1034 | 1034 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-565 | 72833-565-30 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1034 | 1034 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1034 | 1034 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6147 | 71285-6147-1 | Magnesium Sulfate Heptahydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1034 | 1034 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6148 | 71285-6148-1 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1034 | 1034 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1034 | 1034 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1034 | 1034 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1034 | 1034 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1034 | 1034 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1034 | 1034 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1034 | 1034 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1034 | 1034 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-040 | 68985-040-94 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1034 | 1034 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1035 | 1035 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-974 | 69194-974-10 | 974 PHENYLEPHRINE HCL 50MG/250ML | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-289 | 70004-289-67 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-044 | 69389-044-26 | Medroxyprogesterone Acetate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5239 | 26436-5239-8 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1035 | 1035 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6148 | 71285-6148-1 | Magnesium Sulfate Heptahydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6048 | 71285-6048-1 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8096 | 72196-8096-1 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1035 | 1035 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6065 | 72196-6065-1 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5416 | 72934-5416-2 | Mupirocin; Metronidazole | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1035 | 1035 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1035 | 1035 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1035 | 1035 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1035 | 1035 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-400 | 83298-400-05 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1035 | 1035 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1036 | 1036 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-105 | 71449-105-15 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-042 | 71591-042-50 | Meloxicam | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0333 | 71283-0333-3 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1036 | 1036 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6048 | 71285-6048-1 | Magnesium Sulfate Heptahydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7080 | 71285-7080-1 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8097 | 72196-8097-1 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1036 | 1036 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0408 | 72196-0408-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Lysine Acetate; Serine; Glutamic Acid; Tyrosine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6039 | 71285-6039-1 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1036 | 1036 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1036 | 1036 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1036 | 1036 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-004 | 68985-004-91 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1036 | 1036 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1037 | 1037 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-166 | 73177-166-05 | Phenylephrine | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:1037 | 1037 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metformin Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1037 | 1037 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1337 | 61141-1337-1 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8073 | 71285-8073-1 | Magnesium Sulfate Heptahydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8073 | 71285-8073-1 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1037 | 1037 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-5 | Nadide | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1037 | 1037 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1037 | 1037 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1037 | 1037 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-978 | 69194-978-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1037 | 1037 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-112 | 73177-112-03 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1038 | 1038 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Trophamine 3.5%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1248 | 5446-1248-01 | Methacholine Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0331 | 71283-0331-3 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-2 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6147 | 72196-6147-1 | Magnesium Sulfate Heptahydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6147 | 71285-6147-1 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1038 | 1038 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-010 | 72055-010-01 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 |